[English] 日本語
Yorodumi
- PDB-7m5b: Crystal Structure of human BAK in complex with M3W5_BID -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 7m5b
TitleCrystal Structure of human BAK in complex with M3W5_BID
Components
  • BH3-interacting domain death agonist p15
  • Bcl-2 homologous antagonist/killer
KeywordsAPOPTOSIS / protein-peptide complex
Function / homology
Function and homology information


cysteine-type endopeptidase regulator activity involved in apoptotic process / mitochondrial outer membrane permeabilization / Activation, translocation and oligomerization of BAX / Activation and oligomerization of BAK protein / response to mycotoxin / Activation, myristolyation of BID and translocation to mitochondria / B cell negative selection / BAK complex / BH domain binding / apoptotic process involved in blood vessel morphogenesis ...cysteine-type endopeptidase regulator activity involved in apoptotic process / mitochondrial outer membrane permeabilization / Activation, translocation and oligomerization of BAX / Activation and oligomerization of BAK protein / response to mycotoxin / Activation, myristolyation of BID and translocation to mitochondria / B cell negative selection / BAK complex / BH domain binding / apoptotic process involved in blood vessel morphogenesis / negative regulation of endoplasmic reticulum calcium ion concentration / response to fungus / positive regulation of fibroblast apoptotic process / Release of apoptotic factors from the mitochondria / limb morphogenesis / post-embryonic camera-type eye morphogenesis / endocrine pancreas development / establishment or maintenance of transmembrane electrochemical gradient / positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway / BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members / negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage / B cell apoptotic process / protein targeting to mitochondrion / negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway / activation of cysteine-type endopeptidase activity / regulation of epithelial cell proliferation / establishment of protein localization to membrane / endoplasmic reticulum calcium ion homeostasis / death receptor binding / positive regulation of endoplasmic reticulum unfolded protein response / positive regulation of extrinsic apoptotic signaling pathway / positive regulation of mitochondrial membrane potential / regulation of mitochondrial membrane permeability / calcium ion transport into cytosol / response to UV-C / mitochondrial fusion / fibroblast apoptotic process / Bcl-2 family protein complex / myeloid cell homeostasis / mitochondrial ATP synthesis coupled electron transport / positive regulation of calcium ion transport into cytosol / porin activity / regulation of T cell proliferation / thymocyte apoptotic process / hepatocyte apoptotic process / pore complex / negative regulation of release of cytochrome c from mitochondria / apoptotic mitochondrial changes / regulation of G1/S transition of mitotic cell cycle / positive regulation of proteolysis / positive regulation of IRE1-mediated unfolded protein response / positive regulation of release of cytochrome c from mitochondria / TP53 Regulates Transcription of Genes Involved in Cytochrome C Release / vagina development / B cell homeostasis / extrinsic apoptotic signaling pathway via death domain receptors / intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress / Activation of BAD and translocation to mitochondria / blood vessel remodeling / cellular response to unfolded protein / Pyroptosis / animal organ regeneration / supramolecular fiber organization / negative regulation of peptidyl-serine phosphorylation / positive regulation of intrinsic apoptotic signaling pathway / signal transduction in response to DNA damage / extrinsic apoptotic signaling pathway in absence of ligand / heat shock protein binding / intrinsic apoptotic signaling pathway / release of cytochrome c from mitochondria / regulation of mitochondrial membrane potential / epithelial cell proliferation / establishment of localization in cell / apoptotic signaling pathway / response to gamma radiation / positive regulation of protein-containing complex assembly / response to hydrogen peroxide / response to organic cyclic compound / cellular response to mechanical stimulus / cellular response to UV / intrinsic apoptotic signaling pathway in response to DNA damage / protein-folding chaperone binding / protein-containing complex assembly / response to ethanol / neuron apoptotic process / mitochondrial outer membrane / transmembrane transporter binding / regulation of cell cycle / response to xenobiotic stimulus / positive regulation of apoptotic process / protein heterodimerization activity / negative regulation of cell population proliferation / negative regulation of gene expression / apoptotic process / ubiquitin protein ligase binding / protein-containing complex binding / endoplasmic reticulum / protein homodimerization activity / mitochondrion / membrane
Similarity search - Function
BH3-interacting domain death agonist / BH3 interacting domain (BID) / Apoptosis regulator, Bcl-2, BH3 motif, conserved site / Apoptosis regulator, Bcl-2 family BH3 motif signature. / Apoptosis regulator, Bcl-2, BH1 motif, conserved site / Apoptosis regulator, Bcl-2 family BH1 motif signature. / Apoptosis regulator, Bcl-2, BH2 motif, conserved site / Apoptosis regulator, Bcl-2 family BH2 motif signature. / BCL (B-Cell lymphoma); contains BH1, BH2 regions / Bcl-2 family ...BH3-interacting domain death agonist / BH3 interacting domain (BID) / Apoptosis regulator, Bcl-2, BH3 motif, conserved site / Apoptosis regulator, Bcl-2 family BH3 motif signature. / Apoptosis regulator, Bcl-2, BH1 motif, conserved site / Apoptosis regulator, Bcl-2 family BH1 motif signature. / Apoptosis regulator, Bcl-2, BH2 motif, conserved site / Apoptosis regulator, Bcl-2 family BH2 motif signature. / BCL (B-Cell lymphoma); contains BH1, BH2 regions / Bcl-2 family / Bcl-2, Bcl-2 homology region 1-3 / Bcl2-like / Apoptosis regulator proteins, Bcl-2 family / BCL2-like apoptosis inhibitors family profile. / Bcl-2-like superfamily
Similarity search - Domain/homology
COPPER (II) ION / BH3-interacting domain death agonist / Bcl-2 homologous antagonist/killer
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.85 Å
AuthorsSingh, G. / Aggarwal, A. / Moldoveanu, T.
CitationJournal: Nat Commun / Year: 2022
Title: Structural basis of BAK activation in mitochondrial apoptosis initiation.
Authors: Singh, G. / Guibao, C.D. / Seetharaman, J. / Aggarwal, A. / Grace, C.R. / McNamara, D.E. / Vaithiyalingam, S. / Waddell, M.B. / Moldoveanu, T.
History
DepositionMar 23, 2021Deposition site: RCSB / Processing site: RCSB
Revision 1.0Jan 12, 2022Provider: repository / Type: Initial release
Revision 1.1Aug 3, 2022Group: Database references / Category: citation / citation_author
Item: _citation.country / _citation.journal_abbrev ..._citation.country / _citation.journal_abbrev / _citation.journal_id_CSD / _citation.journal_id_ISSN / _citation.journal_volume / _citation.page_first / _citation.page_last / _citation.pdbx_database_id_DOI / _citation.pdbx_database_id_PubMed / _citation.title / _citation.year
Revision 1.2Oct 18, 2023Group: Data collection / Refinement description
Category: chem_comp_atom / chem_comp_bond / pdbx_initial_refinement_model

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Bcl-2 homologous antagonist/killer
B: BH3-interacting domain death agonist p15
C: Bcl-2 homologous antagonist/killer
D: BH3-interacting domain death agonist p15
hetero molecules


Theoretical massNumber of molelcules
Total (without water)43,1345
Polymers43,0704
Non-polymers641
Water5,477304
1
A: Bcl-2 homologous antagonist/killer
B: BH3-interacting domain death agonist p15
hetero molecules


Theoretical massNumber of molelcules
Total (without water)21,5993
Polymers21,5352
Non-polymers641
Water362
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area2290 Å2
ΔGint-27 kcal/mol
Surface area8780 Å2
MethodPISA
2
C: Bcl-2 homologous antagonist/killer
D: BH3-interacting domain death agonist p15


Theoretical massNumber of molelcules
Total (without water)21,5352
Polymers21,5352
Non-polymers00
Water362
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area2230 Å2
ΔGint-25 kcal/mol
Surface area8580 Å2
MethodPISA
Unit cell
Length a, b, c (Å)50.190, 83.176, 110.030
Angle α, β, γ (deg.)90.000, 90.000, 90.000
Int Tables number19
Space group name H-MP212121
Noncrystallographic symmetry (NCS)NCS domain:
IDEns-IDDetails
11(chain A and (resid 22 through 49 or (resid 55...
21(chain C and (resid 22 through 62 or (resid 66...
12(chain B and (resid 81 through 103 or (resid 104...
22chain D

NCS domain segments:
Dom-IDComponent-IDEns-IDSelection detailsAuth asym-IDAuth seq-ID
111(chain A and (resid 22 through 49 or (resid 55...A22 - 49
121(chain A and (resid 22 through 49 or (resid 55...A55 - 56
131(chain A and (resid 22 through 49 or (resid 55...A21 - 185
141(chain A and (resid 22 through 49 or (resid 55...A21 - 185
151(chain A and (resid 22 through 49 or (resid 55...A21 - 185
161(chain A and (resid 22 through 49 or (resid 55...A120
171(chain A and (resid 22 through 49 or (resid 55...A120
181(chain A and (resid 22 through 49 or (resid 55...A21 - 185
191(chain A and (resid 22 through 49 or (resid 55...A21 - 185
1101(chain A and (resid 22 through 49 or (resid 55...A21 - 185
1111(chain A and (resid 22 through 49 or (resid 55...A21 - 185
211(chain C and (resid 22 through 62 or (resid 66...C22 - 62
221(chain C and (resid 22 through 62 or (resid 66...C66 - 68
231(chain C and (resid 22 through 62 or (resid 66...C21 - 185
241(chain C and (resid 22 through 62 or (resid 66...C21 - 185
251(chain C and (resid 22 through 62 or (resid 66...C21 - 185
261(chain C and (resid 22 through 62 or (resid 66...C21 - 185
112(chain B and (resid 81 through 103 or (resid 104...B0
212chain DD81 - 104

NCS ensembles :
ID
1
2

-
Components

#1: Protein Bcl-2 homologous antagonist/killer / Apoptosis regulator BAK / Bcl-2-like protein 7 / Bcl2-L-7


Mass: 18698.918 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: BAK1, BAK, BCL2L7, CDN1 / Plasmid: pNIC28Bsa4 / Production host: Escherichia coli (E. coli) / Strain (production host): T7 placI/Y / References: UniProt: Q16611
#2: Protein/peptide BH3-interacting domain death agonist p15 / p15 BID


Mass: 2836.194 Da / Num. of mol.: 2 / Source method: obtained synthetically / Source: (synth.) Homo sapiens (human) / References: UniProt: P55957
#3: Chemical ChemComp-CU / COPPER (II) ION / Copper


Mass: 63.546 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: Cu
#4: Water ChemComp-HOH / water / Water


Mass: 18.015 Da / Num. of mol.: 304 / Source method: isolated from a natural source / Formula: H2O
Has ligand of interestN

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.75 Å3/Da / Density % sol: 55.2 % / Mosaicity: 0.299 °
Crystal growTemperature: 293 K / Method: evaporation / pH: 6.5 / Details: 15% PEG 4000 0.2 M NaCl 0.1 MES 6.5

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: APS / Beamline: 22-ID / Wavelength: 1 Å
DetectorType: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Oct 4, 2018
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1 Å / Relative weight: 1
ReflectionResolution: 1.85→50 Å / Num. obs: 39200 / % possible obs: 96.5 % / Redundancy: 5.7 % / Rmerge(I) obs: 0.037 / Rpim(I) all: 0.016 / Rrim(I) all: 0.041 / Χ2: 0.915 / Net I/σ(I): 14.3 / Num. measured all: 222410
Reflection shell

Diffraction-ID: 1

Resolution (Å)Redundancy (%)Rmerge(I) obsNum. unique obsCC1/2Rpim(I) allRrim(I) allΧ2% possible all
1.85-1.884.20.86316980.6750.4370.9730.75785.2
1.88-1.924.60.82818510.6960.4040.9270.85392.3
1.92-1.9550.77618800.6980.3650.8620.86694.2
1.95-1.995.40.59319720.8480.2740.6560.83598.4
1.99-2.045.70.47319490.9080.2120.520.83897.2
2.04-2.085.70.37819740.9330.1720.4170.88198.8
2.08-2.145.60.28219490.9460.130.3120.8897.4
2.14-2.195.30.21218710.9640.0990.2360.87892.7
2.19-2.265.90.20319550.9670.090.2231.06797.8
2.26-2.336.20.16119640.9840.0690.1760.93398.4
2.33-2.416.30.1320130.9860.0550.1410.87898.7
2.41-2.516.20.10219960.9910.0440.1110.89699.8
2.51-2.636.10.07820010.9940.0330.0850.91498.8
2.63-2.765.90.05820030.9960.0250.0630.87799
2.76-2.945.70.04420120.9960.0190.0480.90399.1
2.94-3.165.40.03318750.9970.0150.0370.95191.5
3.16-3.486.10.02820310.9980.0120.0311.05998.7
3.48-3.996.20.02320550.9980.010.0251.10799.8
3.99-5.0260.01920900.9990.0080.0210.97599.4
5.02-505.60.01620610.9990.0070.0180.79493

-
Processing

Software
NameVersionClassification
PHENIX1.16_3546refinement
HKL-20001.11.1_2575data scaling
PDB_EXTRACT3.25data extraction
PHENIXphasing
HKL-2000data reduction
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 2vwz
Resolution: 1.85→37.078 Å / SU ML: 0.18 / Cross valid method: THROUGHOUT / σ(F): 1.35 / Phase error: 20.02 / Stereochemistry target values: ML
RfactorNum. reflection% reflection
Rfree0.2051 1811 5.08 %
Rwork0.1697 33859 -
obs0.1715 35670 88.94 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso max: 78.42 Å2 / Biso mean: 24.5196 Å2 / Biso min: 6.29 Å2
Refinement stepCycle: final / Resolution: 1.85→37.078 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms2900 0 1 304 3205
Biso mean--17.35 34.15 -
Num. residues----366
Refine LS restraints NCS
Ens-IDDom-IDAuth asym-IDNumberRefine-IDRmsType
11A930X-RAY DIFFRACTION8.656TORSIONAL
12C930X-RAY DIFFRACTION8.656TORSIONAL
21B144X-RAY DIFFRACTION8.656TORSIONAL
22D144X-RAY DIFFRACTION8.656TORSIONAL
LS refinement shell

Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0

Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection Rwork% reflection obs (%)
1.85-1.90010.3361650.3069148651
1.9001-1.9560.2665910.2598183963
1.956-2.01910.26411230.2115224278
2.0191-2.09130.23111480.1953259190
2.0913-2.1750.20711430.1727260991
2.175-2.2740.22571460.1718280296
2.274-2.39380.20381670.1639286099
2.3938-2.54380.21341700.1675285899
2.5438-2.74010.21561570.166288799
2.7401-3.01580.21351580.162290899
3.0158-3.45190.20271260.1646281694
3.4519-4.34790.16061630.14612975100
4.3479-37.0780.19581540.1667298695
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL112)L122)L132)L222)L232)L332)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T112)T122)T132)T222)T232)T332)Origin x (Å)Origin y (Å)Origin z (Å)
11.42280.8293-0.09870.8291-0.00521.6147-0.12920.1998-0.1648-0.43010.08030.06770.3777-0.19-0.01530.3038-0.06560.02950.16680.0160.116210.392141.924553.9402
20.9470.59610.69631.11550.32590.754-0.03660.1112-0.1631-0.25230.0726-0.14530.04640.26811.08050.1390.03640.02890.16190.03330.13918.641943.780763.1806
30.4775-0.1163-0.06910.58750.00940.927-0.02070.05430.0467-0.1470.03010.0572-0.0202-0.0478-0.11280.09410.0001-0.00450.09780.06160.07299.967349.170262.4943
41.1911-0.12060.3320.99510.20170.9384-0.0216-0.15030.0735-0.01640.0104-0.1472-0.09850.0233-0.09420.0602-0.0376-0.01240.1450.02850.124220.776753.461966.4133
50.7356-0.60330.33650.79060.29681.2624-0.0151-0.19050.15680.1998-0.01030.03580.09520.1526-0.20460.1833-0.0060.03260.1297-0.06270.116343.635463.159987.0324
63.91630.21820.53231.62770.70580.87460.0451-0.3412-0.11670.4918-0.04920.10560.2561-0.00180.08080.27110.00940.03110.1681-0.07570.139540.108662.425592.2884
70.07640.0347-0.13420.0158-0.0610.2359-0.0693-0.47220.01850.22810.11950.15040.0462-0.14960.01220.1709-0.01430.00120.2639-0.01970.337429.533150.344880.4454
82.04780.5013-0.18281.27861.09411.7119-0.0376-0.0754-0.05960.08320.04130.00630.06940.0844-0.00160.07330.0077-0.00830.0867-0.00870.084743.296356.481778.9301
91.31650.01060.17240.8109-0.26950.6034-0.1401-0.09010.2428-0.05750.0294-0.0262-0.1505-0.1086-0.11380.10120.0064-0.07560.1797-0.01550.229332.323357.355272.8908
Refinement TLS group
IDRefine-IDRefine TLS-IDSelection detailsAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1chain 'A' and (resid 21 through 69 )A21 - 69
2X-RAY DIFFRACTION2chain 'A' and (resid 70 through 106 )A70 - 106
3X-RAY DIFFRACTION3chain 'A' and (resid 107 through 185 )A107 - 185
4X-RAY DIFFRACTION4chain 'B' and (resid 80 through 104 )B80 - 104
5X-RAY DIFFRACTION5chain 'C' and (resid 21 through 47 )C21 - 47
6X-RAY DIFFRACTION6chain 'C' and (resid 48 through 82 )C48 - 82
7X-RAY DIFFRACTION7chain 'C' and (resid 83 through 100 )C83 - 100
8X-RAY DIFFRACTION8chain 'C' and (resid 101 through 185 )C101 - 185
9X-RAY DIFFRACTION9chain 'D' and (resid 81 through 104 )D81 - 104

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more